[1]
ALNAWMASI, M.S. et al. 2025. CARDIOVASCULAR RISK IN TIRZEPATIDE MANAGEMENT FOR OBESITY IN TYPE 2 DIABETES PATIENTS: A SYSTEMATIC REVIEW. TPM – Testing, Psychometrics, Methodology in Applied Psychology. 32, S3(2025) : Posted 07 July (Aug. 2025), 462–470.